# Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus

> **NCT00335712** · PHASE2 · COMPLETED · sponsor: **Ono Pharma USA Inc** · enrollment: 81 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** ONO-5129

## Key facts

- **NCT ID:** NCT00335712
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335712, "Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00335712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*